Diabetes and Coronary Heart Disease As Risk Factors for Mortality in Older Adults
Overview
Authors
Affiliations
Background: Type 2 diabetes has been described as a coronary heart disease (CHD) "risk equivalent." We tested whether cardiovascular and all-cause mortality rates were similar between participants with prevalent CHD vs diabetes in an older adult population in whom both glucose disorders and preexisting atherosclerosis are common.
Methods: The Cardiovascular Health Study is a longitudinal study of men and women (n=5784) aged > or =65 years at baseline who were followed from baseline (1989/1992-1993) through 2005 for mortality. Diabetes was defined by fasting plasma glucose > or =7.0 mmol/L or use of diabetes control medications. Prevalent CHD was determined by confirmed history of myocardial infarction, angina, or coronary revascularization.
Results: Following multivariable adjustment for other cardiovascular disease risk factors and subclinical atherosclerosis, CHD mortality risk was similar between participants with CHD alone vs diabetes alone (hazard ratio [HR] 1.04, 95% confidence interval [CI], 0.83-1.30). The proportion of mortality attributable to prevalent diabetes (population-attributable risk percent=8.4%) and prevalent CHD (6.7%) was similar in women, but the proportion of mortality attributable to CHD (16.5%) as compared with diabetes (6.4%) was markedly higher in men. Patterns were similar for cardiovascular disease mortality. By contrast, the adjusted relative hazard of total mortality was lower among participants with CHD alone (HR 0.85, 95% CI, 0.75-0.96) as compared with those who had diabetes alone.
Conclusions: Among older adults, diabetes alone confers a risk for cardiovascular mortality similar to that from established clinical CHD. The public health burden of both diabetes and CHD is substantial, particularly among women.
Ribero V, Efthimiou O, Abolhassani N, Alwan H, Bauer D, Henrard S Eur J Clin Invest. 2024; 55(2):e14340.
PMID: 39465996 PMC: 11744924. DOI: 10.1111/eci.14340.
Rella S, Onyiah J, Baker C, Singh V, Her A, Rasouli N Ther Adv Endocrinol Metab. 2023; 14:20420188231207348.
PMID: 37916028 PMC: 10617296. DOI: 10.1177/20420188231207348.
Camara M, Lima K, Freire Y, Souto G, Macedo G, Silva R PLoS One. 2023; 18(10):e0292957.
PMID: 37871003 PMC: 10593220. DOI: 10.1371/journal.pone.0292957.
Lorentzen K, Hernanz R, Pinilla E, Nyengaard J, Wogensen L, Simonsen U Int J Mol Sci. 2023; 24(9).
PMID: 37176139 PMC: 10179165. DOI: 10.3390/ijms24098436.
Salinero-Fort M, Mostaza J, Lahoz C, Cardenas-Valladolid J, Vicente-Diez J, Gomez-Campelo P BMC Geriatr. 2022; 22(1):224.
PMID: 35303825 PMC: 8931574. DOI: 10.1186/s12877-022-02893-z.